On 2024/1/16, Professor Yu Bo, Professor Hou Jingbo, Professor Chen Tao, and other clinicians from the Second Affiliated Hospital of Harbin Medical University successfully treated a high-risk PCI patient using the OmniHeart® percutaneous ventricular assist device, developed by Shanghai Dynaheart Medical Technology Co., Ltd. This milestone marks the official launch of the registration clinical trials for this product after years of dedicated development.

The OmniHeart® percutaneous ventricular assist device registration clinical study is a prospective, multicenter, randomized controlled registration trial led by Professor Yu Bo of the Second Affiliated Hospital of Harbin Medical University as the coordinating investigator for the treatment of high-risk PCI.

The clinical enrollment for 2025 year 12 month has been successfully completed.

OmniHeart® Percutaneous Ventricular Assist Device Registration Study

Learn more